Cellebrite DI Ltd.

Fundamentals7.0
Price Action6.0
News Sentiment7.0
AI Rating
7.0

Key Drivers

  • Cash Strength
  • Margin Pressure
  • Premium Valuation

AI
AI Summary

7.0

CLBT is increasingly a federal-workflow and AI efficiency compounder rather than just a niche software name, with FedRAMP High, Genesis adoption, and 21% ARR growth backed by strong cash generation and a $535M net cash position. The key risk is that the stock already prices in continued execution, so any further margin compression, federal procurement slowdown, or leadership disruption could quickly compress an already rich valuation.

AI
MarginPressure
Federal‍

Price Chart

Loading chart...

Financial Metrics

-
Revenue (TTM)
-
Net Income (TTM)
-
EPS (Q)
-
MCAP

Deep Analysis

Research tool. Not personalized advice.

Fundamental Analysis

7.0

Key Financial Insights:

  • Cash Strength
  • Margin Pressure
  • Premium Valuation

CLBT shows strong profitability, liquidity, and cash conversion, but margin compression and a rich valuation mean the stock depends on sustained execution more than multiple expansion.

StrongCashFlow
PremiumValuation

Price Behavior

6.0
Research tool. Not personalized advice. Technical analysis is for informational purposes only.

Key Price Behavior Insights:

  • Higher-low breakout
  • Stretched momentum
  • Support holding

CLBT is in a constructive short-term uptrend after a sharp rebound to a last-month high, but the move is stretched and now faces resistance near $15.50-$15.90.

bullish
overbought
Support Level: $12.40-$12.70
Resistance Level: $15.50-$15.90

Fast rebound from the late-June low into a new high suggests strong short-term momentum but elevated pullback risk

Sentiment & News

7.0

Key News Insights:

  • Federal demand
  • Product adoption
  • AI innovation

CLBT headlines point to improving growth momentum as federal demand reaccelerates, FedRAMP High supports adoption, and new AI-driven products like Genesis strengthen commercial traction.

CLBT
AI

The news is incrementally positive for CLBT, reinforcing a stronger growth outlook as compliance wins and product expansion translate into faster revenue traction